Hongbo Pharmaceuticals: Announcement on Replacing the Sponsoring Partner

robot
Abstract generation in progress

Securities Daily News reported that on February 25, Hongbo Pharmaceutical announced that CITIC Securities, as the sponsor for the company’s initial public offering and listing on the Growth Enterprise Market, originally designated Mr. Wang Qi and Mr. Li Song as the company’s continuous supervision sponsors responsible for sponsorship and ongoing supervision. Due to personal work adjustments, Mr. Wang Qi no longer serves as the company’s continuous supervision sponsor. The statutory continuous supervision period for the company is until December 31, 2025. Since the 2025 annual report has not yet been disclosed, to ensure the orderly progress of related work, CITIC Securities has appointed Mr. Yuan Binlong to continue performing the continuous supervision duties.

(Edited by Ren Shibi)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)